A randomized open label phase-II clinical trial with or without infusion of plasma from subjects aft… - SLUB Dresden

Medientyp: E-Artikel

Titel: A randomized open label phase-II clinical trial with or without infusion of plasma from subjects after convalescence of SARS-CoV-2 infection in high-risk patients with confirmed severe SARS-CoV-2 disease (RECOVER) : a structured summary of a study protocol for a randomised controlled trial

Beteiligte: Janssen, Maike [Verfasser:in] ; Schäkel, Ulrike [Verfasser:in] ; Djuika, Carine F. [Verfasser:in] ; Krisam, Johannes [Verfasser:in] ; Stermann, Jacek [Verfasser:in] ; Kriegsmann, Katharina [Verfasser:in] ; Haberbosch, Isabella [Verfasser:in] ; Novotný, Jan Philipp [Verfasser:in] ; Weber, Stefan F. [Verfasser:in] ; Vehreschild, Maria J. G. T. [Verfasser:in] ; Bornhäuser, Martin [Verfasser:in] ; Bullinger, Lars [Verfasser:in] ; Schmitt, Michael [Verfasser:in] ; Liebregts, Tobias [Verfasser:in] ; Dreger, Peter [Verfasser:in] ; Lorenz, Hanns-Martin [Verfasser:in] ; Płaszczyca, Anna Maria [Verfasser:in] ; Bartenschlager, Ralf [Verfasser:in] ; Müller, Barbara [Verfasser:in] ; Kräusslich, Hans-Georg [Verfasser:in] ; Halama, Niels [Verfasser:in] ; Jäger, Dirk [Verfasser:in] ; Schlenk, Richard Friedrich [Verfasser:in] ; Leo, Albrecht [Verfasser:in] ; Meuer, Stefan [Verfasser:in] ; Weigand, Markus A. [Verfasser:in] ; Motsch, Johann [Verfasser:in] ; Merle, Uta [Verfasser:in] ; Denkinger, Claudia M. [Verfasser:in] ; Müller-Tidow, Carsten [Verfasser:in]

Erschienen: 06 October 2020

Sprache: Englisch

DOI: 10.1186/s13063-020-04735-y

Identifikator:

Schlagwörter: convalescent plasma ; COVID-19 ; early application ; high-risk patients with severe disease ; protocol ; Randomised controlled trial

Entstehung:

Anmerkungen:

Beschreibung: Primary objectives

Zugangsstatus: Freier Zugang